共 8 条
[2]
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
[J].
ARTHRITIS AND RHEUMATISM,
2006, 54 (09)
:2793-2806
[3]
Rituximab in the treatment of dermatomyositism - An opel-label pilot study
[J].
ARTHRITIS AND RHEUMATISM,
2005, 52 (02)
:601-607
[4]
Narat S, 2005, HAEMATOLOGICA, V90, P1273
[5]
Rituximab treatment in patients with primary Sjogren's syndrome
[J].
ARTHRITIS AND RHEUMATISM,
2005, 52 (09)
:2740-2750
[6]
Singh F, 2005, CUTIS, V76, P186
[7]
Classification criteria for psoriatic arthritis - Development of new criteria from a large international study
[J].
ARTHRITIS AND RHEUMATISM,
2006, 54 (08)
:2665-2673